Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers

類似資料

• Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers
  著者:: Tursi, Antonio, 等
  出版事項: (2019)
• Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first “real-life” experience in primary gastroenterology centers in Italy
  著者:: Tursi, Antonio, 等
  出版事項: (2014)
• The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study
  著者:: Tursi, Antonio, 等
  出版事項: (2021)
• Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
  著者:: Tursi, Antonio, 等
  出版事項: (2010)
• Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis
  著者:: Elisei, Walter, 等
  出版事項: (2016)